Literature DB >> 16249843

Group IIA-soluble phospholipase A2 levels in patients with infections after esophageal cancer surgery.

Masaaki Ogawa1, Nobuhiro Sato, Shigeatsu Endo, Masahiro Kojika, Yasunori Yaegashi, Yusuke Kimura, Kenichiro Ikeda, Takeshi Iwaya.   

Abstract

PURPOSE: To examine the changes in blood-soluble phospholipase A(2)-IIA levels caused by surgical stress and postoperative infections.
METHODS: We retrospectively analyzed a prospective database of 40 patients who underwent esophagectomy for esophageal cancer. Nine of these patients had a postoperative infection (E Inf(+) group), and 31 did not have a postoperative infection (E Inf(-) group). The blood sPLA(2)-IIA level was measured using a radioimmunoassay, and whole blood was stimulated with lipopolysaccharide (LPS) to examine the sPLA(2)-IIA production.
RESULTS: In the E Inf(-) group, the blood sPLA(2)-IIA levels peaked on postoperative day (POD) 3 then decreased gradually thereafter. Receiver-operator characteristic statistics based on the sPLA(2)-IIA values on POD 5, which are used to classify postoperative infectious complications, revealed an area under the curve of 0.789. However, stimulation of peripheral blood cells with LPS did not induce the production of sPLA(2)-IIA.
CONCLUSION: During the early postoperative phase, blood sPLA(2)-IIA levels increase according to the surgical stress. Soluble PLA(2)-IIA may be produced at the site of infection or in the liver, but not in the circulating blood. Sustained elevation of the serum sPLA(2)-IIA level, observed even after POD 3, seems to represent a response to postoperative infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16249843     DOI: 10.1007/s00595-005-3059-7

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  15 in total

1.  Randomized study of the benefits of preoperative corticosteroid administration on the postoperative morbidity and cytokine response in patients undergoing surgery for esophageal cancer.

Authors:  Nobuhiro Sato; Keisuke Koeda; Kenichiro Ikeda; Yusuke Kimura; Kiichi Aoki; Takeshi Iwaya; Yuji Akiyama; Kaoru Ishida; Kazuyoshi Saito; Shigeatsu Endo
Journal:  Ann Surg       Date:  2002-08       Impact factor: 12.969

2.  Development of a radioimmunoassay for human group-II phospholipase A2 and demonstration of postoperative elevation.

Authors:  Y Matsuda; M Ogawa; K Sakamoto; S Yamashita; A Kanda; M Kohno; N Yoshida; J Nishijima; A Murata; T Mori
Journal:  Enzyme       Date:  1991

3.  Crucial role of group IIA phospholipase A(2) in oleic acid-induced acute lung injury in rabbits.

Authors:  S Furue; K Kuwabara; K Mikawa; K Nishina; M Shiga; N Maekawa; M Ueno; Y Chikazawa; T Ono; Y Hori; A Matsukawa; M Yoshinaga; H Obara
Journal:  Am J Respir Crit Care Med       Date:  1999-10       Impact factor: 21.405

4.  Expression of group II phospholipase A2 in the liver in acute pancreatitis.

Authors:  K A Talvinen; E A Kemppainen; T J Nevalainen
Journal:  Scand J Gastroenterol       Date:  2001-11       Impact factor: 2.423

5.  Cytokine profile of serum and bronchoalveolar lavage fluids following thoracic esophageal cancer surgery.

Authors:  N Sato; K Koeda; Y Kimura; K Ikeda; M Ogawa; K Saito; S Endo
Journal:  Eur Surg Res       Date:  2001 Jul-Aug       Impact factor: 1.745

6.  Studies on a mechanism by which cytosolic phospholipase A2 regulates the expression and function of type IIA secretory phospholipase A2.

Authors:  H Kuwata; S Yamamoto; Y Miyazaki; S Shimbara; Y Nakatani; H Suzuki; N Ueda; S Yamamoto; M Murakami; I Kudo
Journal:  J Immunol       Date:  2000-10-01       Impact factor: 5.422

7.  Surgical trauma induces group II phospholipase A2 production by neutrophils at a local site after surgery.

Authors:  T Abe; K Sakamoto; S Mita; H Kamohara; Y Hirano; N Kuwahara; M Ogawa
Journal:  Clin Biochem       Date:  1998-03       Impact factor: 3.281

8.  Serum phospholipase A2 in patients with multiple organ failure.

Authors:  K M Nyman; W Uhl; J Forsström; M Büchler; H G Beger; T J Nevalainen
Journal:  J Surg Res       Date:  1996-01       Impact factor: 2.192

9.  Bactericidal group IIA phospholipase A2 in serum of patients with bacterial infections.

Authors:  Juha O Grönroos; Veli J O Laine; Timo J Nevalainen
Journal:  J Infect Dis       Date:  2002-05-31       Impact factor: 5.226

10.  Hydrolysis of surfactant-associated phosphatidylcholine by mammalian secretory phospholipases A2.

Authors:  R D Hite; M C Seeds; R B Jacinto; R Balasubramanian; M Waite; D Bass
Journal:  Am J Physiol       Date:  1998-10
View more
  3 in total

1.  Targeting antibacterial agents by using drug-carrying filamentous bacteriophages.

Authors:  Iftach Yacoby; Marina Shamis; Hagit Bar; Doron Shabat; Itai Benhar
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

2.  Serum levels of secreted group IIA phospholipase A(2) in benign prostatic hyperplasia and prostate cancer: a biomarker for inflammation or neoplasia?

Authors:  Mario Menschikowski; Albert Hagelgans; Susanne Fuessel; Olga A Mareninova; Volker Neumeister; Manfred P Wirth; Gabriele Siegert
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

3.  Plasma secretory phospholipase A2-IIa as a potential biomarker for lung cancer in patients with solitary pulmonary nodules.

Authors:  Elena Kupert; Marshall Anderson; Yin Liu; Paul Succop; Linda Levin; Jiang Wang; Kathryn Wikenheiser-brokamp; Pingping Chen; Susan M Pinney; Trudy Macdonald; Zhongyun Dong; Sandra Starnes; Shan Lu
Journal:  BMC Cancer       Date:  2011-12-09       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.